Investor Presentaiton slide image

Investor Presentaiton

Consolidated Profit & Loss Statement METROPOLIS The Pathology Specialist Profit & Loss (Rs. Crs.) Revenue from Operations Cost of Material Consumed Laboratory testing charges FY22 FY21 FY20 FY19 FY18 1,228.3 997.8 855.5 760.1 643.6 276.1 252.2 204.1 173.5 145.9 6.9 5.4 6.9 5.6 5.7 Gross Profit 945.3 740.1 644.5 581.0 492.0 Gross Profit (%) 77.0% 74.18% 75.33% 76.44% 76.44% Employee Expenses 238.9 206.4 190.2 172.7 145.8 Other Expenses 357.6 245.7 222.4 202.8 173.7 EBIDTA 348.8 288.0 231.9 205.4 172.5 EBIDTA (%) 28.4% 28.9% 27.1% 27.0% 26.8% Other Income 13.4 10.0 8.3 8.8 11.3 Depreciation 63.2 45.9 39.3 20.1 19.2 EBIT 299.1 252.1 201.0 188.4 164.6 EBIT (%) 24.3% 25.3% 23.5% 24.8% 25.6% Finance Cost 21.6 7.8 7.2 0.5 1.2 Exceptional Items 15.9* 0.0 24.5 6.3 Share of Profit/Loss from JV 0.0 0.0 -0.5 -1.4 Profit Before Tax 293.4 244.3 168.7 186.5 163.4 Tax 78.7 61.0 41.2 62.9 51.8 Profit After Tax 214.7 183.3 127.6 123.6 111.6 Profit After Tax (%) 17.5% 18.4% 14.9% 16.4% 17.3% *Exceptional Item is on account of settlement with Global Hospital of past dues 61
View entire presentation